rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
21
|
pubmed:dateCreated |
1990-12-7
|
pubmed:abstractText |
We report the results of the Heparin-Aspirin Reperfusion Trial, a collaborative study comparing early intravenous heparin with oral aspirin as adjunctive treatment when recombinant tissue plasminogen activator (rt-PA) is used for coronary thrombolysis during acute myocardial infarction.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0028-4793
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
22
|
pubmed:volume |
323
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1433-7
|
pubmed:dateRevised |
2010-3-24
|
pubmed:meshHeading |
pubmed-meshheading:2122251-Administration, Oral,
pubmed-meshheading:2122251-Aspirin,
pubmed-meshheading:2122251-Drug Therapy, Combination,
pubmed-meshheading:2122251-Female,
pubmed-meshheading:2122251-Hemorrhage,
pubmed-meshheading:2122251-Heparin,
pubmed-meshheading:2122251-Humans,
pubmed-meshheading:2122251-Infusions, Intravenous,
pubmed-meshheading:2122251-Injections, Intravenous,
pubmed-meshheading:2122251-Male,
pubmed-meshheading:2122251-Middle Aged,
pubmed-meshheading:2122251-Myocardial Infarction,
pubmed-meshheading:2122251-Random Allocation,
pubmed-meshheading:2122251-Recombinant Proteins,
pubmed-meshheading:2122251-Tissue Plasminogen Activator,
pubmed-meshheading:2122251-Vascular Patency
|
pubmed:year |
1990
|
pubmed:articleTitle |
A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction. Heparin-Aspirin Reperfusion Trial (HART) Investigators.
|
pubmed:affiliation |
Department of Medicine, George Washington University, Washington, DC 20037.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|